Based on previous research [22], [23], [24], [25], pharmacological treatments that restore normal metabolic function via manipulation of Mblac1 pathways may be of benefit in the treatment of neurodegenerative disorders, including AD and Parkinson’s disease. Here, MBLAC1 is linked to Alzheimer disease.